DPCD: A PROMISING TREATMENT TO FIGHT ALOPECIA

Alopecia areata is an auto immune disease that can cause hair loss. Basically, your own immune system mistakenly thinks your hair is a foreign matter or sees your hair as a threat and attacks it, thereby killing the hair follicles, leading to hair loss. The exact reason why this happen is still unsolved but is found to be hereditary. The occurrence or when alopecia areata strikes is also puzzle but it maybe cause by some triggering factors like emotional stress or environmental changes.

Alopecia areata is hard to treat especially alopecia totalis and alopecia universalis where a full blown immune system aggressively attacks your hair. Alopecia totalis affects all of the hair on your head causing total head baldness. In alopecia universalis involves all the hair in your body including your pubic hair, body hair, eyebrows and lashes – everything — leaving you completely hairless.

A newly discovered and experimental hair loss control medication called Diphenylcyclopropenone or DPCD is said to be effective against Alopecia and all its variants. DPCD is a clear liquid and applied to areas where you want hair regrowth on the scalp.

DPCD works by luring the immune system away from your hair and attacking DPCD instead. Since DPCD is applied to the skin certain side effect can occur like itching, dry flaking skin, severe eczema, blistering, lightening or darkening of the treated skin and enlarged lymph nodes. As mentioned previously, DPCD is still in it’s experimetal stages and needs to be applied only by a nurse who holds special permits to apply this.

Although DPCD shows promising results because hair growths do occur, DPCD itself is not a hair growth stimulant, it only acts as a decoy to keep the immune system at bay. To increase and stimulate hair regrowth further it is wise to use an herbal-based hair loss treatment like Nisim Biofactors because the scalp is more sensitive to any chemical exposure due to the treatment. Other chemical based hair regrowth stimulants is not an option.